SCHEMBL7962857

SCHEMBL7962857

CCCOc1ccc(OC)cc1C(=N)OCC.F[B-](F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 3/20 0.41
MTNR1B P49286 3/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
LMNA P02545 2/20 0.41
CLK1 P49759 1/20 0.38
KDM4E B2RXH2 6/20 0.38
ALDH1A1 P00352 4/20 0.38
HPGD P15428 3/20 0.38
GAA P10253 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TSHR P16473 3/20 0.37
MAPK1 P28482 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
MAPT P10636 3/20 0.37
HSD17B10 Q99714 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37
ATM Q13315 1/20 0.37
TP53 P04637 1/20 0.36
POLB P06746 2/20 0.36
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7961052 0.91 MTNR1A (0.39) MTNR1AMTNR1BL3MBTL1LMNACLK1
Hydrochloric Acid SCHEMBL4697925 0.85 MTNR1A (0.41) MTNR1AMTNR1BL3MBTL1LMNACLK1
SCHEMBL7963098 0.84 HTR2C (0.40) L3MBTL1LMNAKDM4EALDH1A1HPGD
SCHEMBL3734867 0.83 MAPT (0.50) KDM4EALDH1A1HPGDGAATSHR
SCHEMBL7950395 0.83 PTGER1 (0.42) L3MBTL1KDM4EALDH1A1HPGDSMN1; SMN2
Hydrochloric Acid SCHEMBL3734866 0.82 MAPT (0.49) KDM4EALDH1A1HPGDGAATSHR
SCHEMBL11630096 0.81 MTNR1A (0.46) MTNR1AMTNR1BLMNACLK1KDM4E
SCHEMBL7965360 0.80 MAPT (0.38) L3MBTL1LMNAKDM4EALDH1A1HPGD
SCHEMBL7962020 0.79 PRSS1 (0.47) MTNR1AMTNR1BLMNACLK1KDM4E
SCHEMBL11628940 0.79 LMNA (0.42) L3MBTL1LMNAKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6200980-B1 ADMINISTERING PHENYL PURINONE COMPOUND FOR TREATING PRECANCEROUS LEISONS CELL PATHWAYS, INC. 2001-03-13 US disclosed
EP-0352960-B1 Purine compounds, process for their preparation and pharmaceutical compositions SMITH KLINE FRENCH LAB (GB) 1994-10-26 EP disclosed
US-5073559-A 2-Substituted purinone having phosphodiesterase inhibitory activity SMITH KLINE & FRENCH LABORATORIES, LTD. (GB) 1991-12-17 US disclosed
EP-0352960-A2 Purine compounds, process for their preparation and pharmaceutical compositions SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1990-01-31 EP disclosed